Meanwhile, low expression levels of TBRII have been observed in chronic myeloid leukemia and colon cancer patients, and mutations in TBRII are frequently found in colon cancer, gastric cancer, ovarian cancer, and nonsmall cell lung carcinoma [22]. This evidence concerns the gene TGFBR2 and gastric cancer.